Strain conformation, primary structure and the propagation of the yeast prion [PSI+]

[1]  Aaron Derdowski,et al.  Dominant Prion Mutants Induce Curing Through Pathways That Promote Chaperone-Mediated Disaggregation , 2011, Nature Structural &Molecular Biology.

[2]  Suzanne S. Sindi,et al.  A Size Threshold Limits Prion Transmission and Establishes Phenotypic Diversity , 2010, Science.

[3]  Julie Grantham,et al.  The Polarisome Is Required for Segregation and Retrograde Transport of Protein Aggregates , 2010, Cell.

[4]  H. Pelham,et al.  Arrestin-Mediated Endocytosis of Yeast Plasma Membrane Transporters , 2009, Traffic.

[5]  Gary D. Bader,et al.  Bayesian Modeling of the Yeast SH3 Domain Interactome Predicts Spatiotemporal Dynamics of Endocytosis Proteins , 2009, PLoS biology.

[6]  B. Chesebro,et al.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. , 2009, Annual review of biochemistry.

[7]  S. Lindquist,et al.  Unraveling infectious structures, strain variants and species barriers for the yeast prion [PSI+] , 2009, Nature Structural &Molecular Biology.

[8]  S. Winder,et al.  The WASP homologue Las17 activates the novel actin-regulatory activity of Ysc84 to promote endocytosis in yeast. , 2009, Molecular biology of the cell.

[9]  Byron J. T. Morgan,et al.  The Number and Transmission of [PSI +] Prion Seeds (Propagons) in the Yeast Saccharomyces cerevisiae , 2009, PloS one.

[10]  J. Weissman,et al.  In vivo monitoring of the prion replication cycle reveals a critical role for Sis1 in delivering substrates to Hsp104. , 2008, Molecular cell.

[11]  S. Emr,et al.  Arrestin-Related Ubiquitin-Ligase Adaptors Regulate Endocytosis and Protein Turnover at the Cell Surface , 2008, Cell.

[12]  E. Craig,et al.  Specificity of the J-protein Sis1 in the propagation of 3 yeast prions , 2008, Proceedings of the National Academy of Sciences.

[13]  S. Lindquist,et al.  Hsp104, Hsp70 and Hsp40 interplay regulates formation, growth and elimination of Sup35 prions , 2008, The EMBO journal.

[14]  Daniel Kaganovich,et al.  Misfolded proteins partition between two distinct quality control compartments , 2008, Nature.

[15]  S. Lindquist,et al.  Screening for Amyloid Aggregation by Semi-Denaturing Detergent-Agarose Gel Electrophoresis , 2008, Journal of visualized experiments : JoVE.

[16]  B. Bukau,et al.  Substrate threading through the central pore of the Hsp104 chaperone as a common mechanism for protein disaggregation and prion propagation , 2008, Molecular microbiology.

[17]  E. Williams,et al.  The elk PRNP codon 132 polymorphism controls cervid and scrapie prion propagation. , 2008, The Journal of general virology.

[18]  P. Lantos,et al.  Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman. , 2007, Archives of neurology.

[19]  Jonathan S. Weissman,et al.  The structural basis of yeast prion strain variants , 2007, Nature.

[20]  K. Abid,et al.  The prion strain phenomenon: molecular basis and unprecedented features. , 2007, Biochimica et biophysica acta.

[21]  Jonathan S. Weissman,et al.  The physical basis of how prion conformations determine strain phenotypes , 2006, Nature.

[22]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[23]  D. Masison,et al.  N-Terminal Domain of Yeast Hsp104 Chaperone Is Dispensable for Thermotolerance and Prion Propagation but Necessary for Curing Prions by Hsp104 Overexpression , 2006, Genetics.

[24]  Y. Chernoff,et al.  Modulation of Prion Formation, Aggregation, and Toxicity by the Actin Cytoskeleton in Yeast , 2006, Molecular and Cellular Biology.

[25]  M. Tuite,et al.  Chaperoning prions: the cellular machinery for propagating an infectious protein? , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  S. Lindquist,et al.  Structural insights into a yeast prion illuminate nucleation and strain diversity , 2005, Nature.

[27]  J. Weissman,et al.  Mechanism of Cross-Species Prion Transmission An Infectious Conformation Compatible withTwo Highly Divergent Yeast Prion Proteins , 2005, Cell.

[28]  S. Sreevatsan,et al.  An overview of transmissible spongiform encephalopathies , 2004, Animal Health Research Reviews.

[29]  Peter Chien,et al.  Emerging principles of conformation-based prion inheritance. , 2004, Annual review of biochemistry.

[30]  Roger Cooke,et al.  Conformational variations in an infectious protein determine prion strain differences , 2004, Nature.

[31]  R. Diaz-Avalos,et al.  Protein-only transmission of three yeast prion strains , 2004, Nature.

[32]  J. Buchner,et al.  The Prion Curing Agent Guanidinium Chloride Specifically Inhibits ATP Hydrolysis by Hsp104* , 2004, Journal of Biological Chemistry.

[33]  D. Kryndushkin,et al.  Yeast [PSI+] Prion Aggregates Are Formed by Small Sup35 Polymers Fragmented by Hsp104* , 2003, Journal of Biological Chemistry.

[34]  M. Tuite,et al.  Propagation of yeast prions , 2003, Nature Reviews Molecular Cell Biology.

[35]  M. Tuite,et al.  Analysis of the generation and segregation of propagons: entities that propagate the [PSI+] prion in yeast. , 2003, Genetics.

[36]  R. Wickner,et al.  Interactions among prions and prion “strains” in yeast , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Masison,et al.  Guanidine Hydrochloride Inhibits Hsp104 Activity In Vivo: A Possible Explanation for Its Effect in Curing Yeast Prions , 2001, Current Microbiology.

[38]  M. Tuite,et al.  The elimination of the yeast [PSI+] prion by guanidine hydrochloride is the result of Hsp104 inactivation , 2001, Molecular microbiology.

[39]  J. Weissman,et al.  Conformational diversity in a yeast prion dictates its seeding specificity , 2001, Nature.

[40]  J. Weissman,et al.  Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro- converted Sup35 protein. , 2000, Science.

[41]  J. Weissman,et al.  Molecular Basis of a Yeast Prion Species Barrier , 2000, Cell.

[42]  V. Moreau,et al.  The Saccharomyces cerevisiae homologue of human Wiskott-Aldrich syndrome protein Las17p interacts with the Arp2/3 complex. , 1999, Molecular biology of the cell.

[43]  Y. Chernoff,et al.  Genetic study of interactions between the cytoskeletal assembly protein sla1 and prion-forming domain of the release factor Sup35 (eRF3) in Saccharomyces cerevisiae. , 1999, Genetics.

[44]  P. Zhou,et al.  The PNM2 mutation in the prion protein domain of SUP35 has distinct effects on different variants of the [PSI+] prion in yeast , 1999, Current Genetics.

[45]  M. Tuite,et al.  Mechanism of inhibition of Ψ+ prion determinant propagation by a mutation of the N‐terminus of the yeast Sup35 protein , 1998, The EMBO journal.

[46]  Andrew F. Hill,et al.  The same prion strain causes vCJD and BSE , 1997, Nature.

[47]  M. Zeidler,et al.  Codon 129 genotype and new variant CJD , 1997, The Lancet.

[48]  K. Wüthrich,et al.  Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Lindquist,et al.  Self-Seeded Fibers Formed by Sup35, the Protein Determinant of [PSI +], a Heritable Prion-like Factor of S. cerevisiae , 1997, Cell.

[50]  Y. Chernoff,et al.  Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. , 1996, Genetics.

[51]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[52]  S W Liebman,et al.  Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. , 1995, Science.

[53]  C. Nierras,et al.  The dominant PNM2- mutation which eliminates the psi factor of Saccharomyces cerevisiae is the result of a missense mutation in the SUP35 gene. , 1994, Genetics.

[54]  B. Cox,et al.  Extrachromosomal elements in a super-suppression system of yeast I. A nuclear gene controlling the inheritance of the extrachromosomal elements , 1971, Heredity.

[55]  S. Liebman,et al.  Analysis of amyloid aggregates using agarose gel electrophoresis. , 2006, Methods in enzymology.